A clear genotype–phenotype correlation exists for BRCA2 mutations, where the central part of the gene (nt 3035–6629 in exon 11) is named the ovarian cancer cluster region (OCCR) because mutations within it are associated with an increased ovarian: breast cancer ratio. The gene discussed is BRCA2; the disease is ovarian carcinoma.